Antipodes Partners LTD Schrodinger, Inc. Transaction History
Antipodes Partners LTD
- $3.16 Billion
- Q1 2025
A detailed history of Antipodes Partners LTD transactions in Schrodinger, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,878 shares of SDGR stock, worth $44,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,878Holding current value
$44,771% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SDGR
# of Institutions
247Shares Held
67.6MCall Options Held
677KPut Options Held
228K-
Black Rock Inc. New York, NY8.52MShares$203 Million0.0% of portfolio
-
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$166 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$156 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.8MShares$114 Million2.71% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$104 Million0.02% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.48B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...